Literature DB >> 33752856

Sepsis-Associated Acute Kidney Injury.

Carlos L Manrique-Caballero1, Gaspar Del Rio-Pertuz2, Hernando Gomez3.   

Abstract

Sepsis-associated acute kidney injury (S-AKI) is a common and life-threatening complication in hospitalized and critically ill patients. It is characterized by rapid deterioration of renal function associated with sepsis. The pathophysiology of S-AKI remains incompletely understood, so most therapies remain reactive and nonspecific. Possible pathogenic mechanisms to explain S-AKI include microcirculatory dysfunction, a dysregulated inflammatory response, and cellular metabolic reprogramming. In addition, several biomarkers have been developed in an attempt to improve diagnostic sensitivity and specificity of S-AKI. This article discusses the current understanding of S-AKI, recent advances in pathophysiology and biomarker development, and current preventive and therapeutic approaches.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AKI; Biomarkers; Inflammation; Metabolic reprogramming; Microcirculation; Sepsis

Mesh:

Substances:

Year:  2021        PMID: 33752856      PMCID: PMC7995616          DOI: 10.1016/j.ccc.2020.11.010

Source DB:  PubMed          Journal:  Crit Care Clin        ISSN: 0749-0704            Impact factor:   3.598


  128 in total

1.  Early goal-directed therapy in the treatment of severe sepsis and septic shock.

Authors:  E Rivers; B Nguyen; S Havstad; J Ressler; A Muzzin; B Knoblich; E Peterson; M Tomlanovich
Journal:  N Engl J Med       Date:  2001-11-08       Impact factor: 91.245

Review 2.  Sepsis, systemic inflammatory response, and multiple organ dysfunction: the mystery continues.

Authors:  Donald E Fry
Journal:  Am Surg       Date:  2012-01       Impact factor: 0.688

3.  Urinary netrin-1 and KIM-1 as early biomarkers for septic acute kidney injury.

Authors:  Yuexing Tu; Hui Wang; Renhua Sun; Yin Ni; Leilei Ma; Fei Xv; Xiuping Hu; Lingzhi Jiang; Aiping Wu; Xv Chen; Minhua Chen; Jingquan Liu; Fang Han
Journal:  Ren Fail       Date:  2014-08-26       Impact factor: 2.606

4.  Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock.

Authors:  Anand Kumar; Daniel Roberts; Kenneth E Wood; Bruce Light; Joseph E Parrillo; Satendra Sharma; Robert Suppes; Daniel Feinstein; Sergio Zanotti; Leo Taiberg; David Gurka; Aseem Kumar; Mary Cheang
Journal:  Crit Care Med       Date:  2006-06       Impact factor: 7.598

5.  Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury.

Authors:  Kiyoshi Mori; H Thomas Lee; Dana Rapoport; Ian R Drexler; Kirk Foster; Jun Yang; Kai M Schmidt-Ott; Xia Chen; Jau Yi Li; Stacey Weiss; Jaya Mishra; Faisal H Cheema; Glenn Markowitz; Takayoshi Suganami; Kazutomo Sawai; Masashi Mukoyama; Cheryl Kunis; Vivette D'Agati; Prasad Devarajan; Jonathan Barasch
Journal:  J Clin Invest       Date:  2005-03       Impact factor: 14.808

6.  High versus low blood-pressure target in patients with septic shock.

Authors:  Pierre Asfar; Ferhat Meziani; Jean-François Hamel; Fabien Grelon; Bruno Megarbane; Nadia Anguel; Jean-Paul Mira; Pierre-François Dequin; Soizic Gergaud; Nicolas Weiss; François Legay; Yves Le Tulzo; Marie Conrad; René Robert; Frédéric Gonzalez; Christophe Guitton; Fabienne Tamion; Jean-Marie Tonnelier; Pierre Guezennec; Thierry Van Der Linden; Antoine Vieillard-Baron; Eric Mariotte; Gaël Pradel; Olivier Lesieur; Jean-Damien Ricard; Fabien Hervé; Damien du Cheyron; Claude Guerin; Alain Mercat; Jean-Louis Teboul; Peter Radermacher
Journal:  N Engl J Med       Date:  2014-03-18       Impact factor: 91.245

7.  Urinary L-type fatty acid-binding protein as a new biomarker of sepsis complicated with acute kidney injury.

Authors:  Kent Doi; Eisei Noiri; Rui Maeda-Mamiya; Tomoko Ishii; Kousuke Negishi; Yoshifumi Hamasaki; Toshiro Fujita; Naoki Yahagi; Hikaru Koide; Takeshi Sugaya; Tsukasa Nakamura
Journal:  Crit Care Med       Date:  2010-10       Impact factor: 7.598

8.  Acute renal failure in critically ill patients: a multinational, multicenter study.

Authors:  Shigehiko Uchino; John A Kellum; Rinaldo Bellomo; Gordon S Doig; Hiroshi Morimatsu; Stanislao Morgera; Miet Schetz; Ian Tan; Catherine Bouman; Ettiene Macedo; Noel Gibney; Ashita Tolwani; Claudio Ronco
Journal:  JAMA       Date:  2005-08-17       Impact factor: 56.272

Review 9.  Long-term risk of mortality and other adverse outcomes after acute kidney injury: a systematic review and meta-analysis.

Authors:  Steven G Coca; Bushra Yusuf; Michael G Shlipak; Amit X Garg; Chirag R Parikh
Journal:  Am J Kidney Dis       Date:  2009-04-05       Impact factor: 8.860

10.  Microcirculatory alterations: potential mechanisms and implications for therapy.

Authors:  Daniel De Backer; Katia Donadello; Fabio Silvio Taccone; Gustavo Ospina-Tascon; Diamantino Salgado; Jean-Louis Vincent
Journal:  Ann Intensive Care       Date:  2011-07-19       Impact factor: 6.925

View more
  19 in total

Review 1.  Experimental models of acute kidney injury for translational research.

Authors:  Neil A Hukriede; Danielle E Soranno; Veronika Sander; Tayla Perreau; Michelle C Starr; Peter S T Yuen; Leah J Siskind; Michael P Hutchens; Alan J Davidson; David M Burmeister; Sarah Faubel; Mark P de Caestecker
Journal:  Nat Rev Nephrol       Date:  2022-02-16       Impact factor: 42.439

2.  Sepsis Encephalopathy Is Partly Mediated by miR370-3p-Induced Mitochondrial Injury but Attenuated by BAM15 in Cecal Ligation and Puncture Sepsis Male Mice.

Authors:  Pratsanee Hiengrach; Peerapat Visitchanakun; Pakteema Tongchairawewat; Ponphisudti Tangsirisatian; Thitiphat Jungteerapanich; Patcharee Ritprajak; Dhammika Leshan Wannigama; Pattarin Tangtanatakul; Asada Leelahavanichkul
Journal:  Int J Mol Sci       Date:  2022-05-13       Impact factor: 6.208

3.  Machine learning for the prediction of acute kidney injury in patients with sepsis.

Authors:  Suru Yue; Shasha Li; Xueying Huang; Jie Liu; Xuefei Hou; Yumei Zhao; Dongdong Niu; Yufeng Wang; Wenkai Tan; Jiayuan Wu
Journal:  J Transl Med       Date:  2022-05-13       Impact factor: 8.440

4.  A Single Oral Dose of Diclofenac Causes Transition of Experimental Subclinical Acute Kidney Injury to Chronic Kidney Disease.

Authors:  Johanna Störmer; Wilfried Gwinner; Katja Derlin; Stephan Immenschuh; Song Rong; Mi-Sun Jang; Nelli Shushakova; Hermann Haller; Faikah Gueler; Robert Greite
Journal:  Biomedicines       Date:  2022-05-22

5.  PICK1 Deficiency Exacerbates Sepsis-Associated Acute Kidney Injury.

Authors:  Qian Dou; Hang Tong; Yichun Yang; Han Zhang; Hua Gan
Journal:  Biomed Res Int       Date:  2021-07-08       Impact factor: 3.246

6.  LncRNA KCNQ1OT1 (potassium voltage-gated channel subfamily Q member 1 opposite strand/antisense transcript 1) aggravates acute kidney injury by activating p38/NF-κB pathway via miR-212-3p/MAPK1 (mitogen-activated protein kinase 1) axis in sepsis.

Authors:  Haixia Wang; Hongbin Mou; Xiaolan Xu; Changhua Liu; Gang Zhou; Bo Gao
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

7.  Salidroside Protects Acute Kidney Injury in Septic Rats by Inhibiting Inflammation and Apoptosis.

Authors:  Heng Fan; Bin-Jie Su; Jian-Wei Le; Jian-Hua Zhu
Journal:  Drug Des Devel Ther       Date:  2022-03-30       Impact factor: 4.162

8.  Impact of central venous pressure on the mortality of patients with sepsis-related acute kidney injury: a propensity score-matched analysis based on the MIMIC IV database.

Authors:  Yan Huo; Xinrui Wang; Bo Li; Jordi Rello; Won Young Kim; Xiaoting Wang; Zhenjie Hu
Journal:  Ann Transl Med       Date:  2022-02

9.  The miR-26a-5p/IL-6 axis alleviates sepsis-induced acute kidney injury by inhibiting renal inflammation.

Authors:  Yanhong Chen; Xu Zhou; Yanhong Wu
Journal:  Ren Fail       Date:  2022-12       Impact factor: 3.222

Review 10.  Pediatric sepsis biomarkers for prognostic and predictive enrichment.

Authors:  Hector R Wong
Journal:  Pediatr Res       Date:  2021-06-14       Impact factor: 3.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.